Mechanisms of Action of Antidepressants: from Neurotransmitter Systems to Signaling Pathways

Overview

Journal Cell Signal

Date 2005 Feb 3

PMID 15683730

Citations 49

Authors

Chirisse Taylor

Ashwana D Fricker

Lakshmi A Devi

Ivone Gomes

Affiliations

Soon will be listed here.

Abstract

Antidepressants are commonly used in the treatment of anxiety and depression, medical conditions that affect approximately 17-20% of the population. The clinical effects of antidepressants take several weeks to manifest, suggesting that these drugs induce adaptive changes in brain structures affected by anxiety and depression. In order to develop shorter-acting and more effective drugs for the treatment of anxiety and depression, it is important to understand how antidepressants bring about their beneficial effects. Recent reports suggest that antidepressants can induce neurogenesis in the adult brain, although the mechanisms involved are not clearly understood. In this review, we describe the different neurotransmitter systems that are affected by anxiety and depression and how they are modulated by antidepressant treatment with a focus on signaling molecules and pathways that are activated during neurotransmitter receptor induced neurogenesis.

Citing Articles

Insights into prescribing patterns for antidepressants: an evidence-based analysis.

Min H, Alemi F BMC Med Inform Decis Mak. 2025; 25(1):42.

PMID: 39871264 PMC: 11773954. DOI: 10.1186/s12911-025-02886-z.

Linking Genome-Wide Association Studies to Pharmacological Treatments for Psychiatric Disorders.

Arnatkeviciute A, Fornito A, Tong J, Pang K, Fulcher B, Bellgrove M JAMA Psychiatry. 2024; 82(2):151-160.

PMID: 39661350 PMC: 11800018. DOI: 10.1001/jamapsychiatry.2024.3846.

Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis.

Saberi A, Ebneabbasi A, Rahimi S, Sarebannejad S, Sen Z, Graf H Mol Psychiatry. 2024; 30(2):736-751.

PMID: 39406999 PMC: 11746144. DOI: 10.1038/s41380-024-02780-6.

Multipronged Electronic Health Record Analysis of Antidepressant Effectiveness on Depression Remission in Patients With Concurrent Depression and Irritable Bowel Syndrome.

Deng A, Espiridion E Cureus. 2024; 16(7):e64968.

PMID: 39161523 PMC: 11331275. DOI: 10.7759/cureus.64968.

Treating Depression in Dementia Patients: A Risk or Remedy-A Narrative Review.

Sultan S Geriatrics (Basel). 2024; 9(3).

PMID: 38804321 PMC: 11130822. DOI: 10.3390/geriatrics9030064.

References

Mannoury la Cour C, Hanoun N, Melfort M, Hen R, Lesch K, Hamon M . GABA(B) receptors in 5-HT transporter- and 5-HT1A receptor-knock-out mice: further evidence of a transduction pathway shared with 5-HT1A receptors. J Neurochem. 2004; 89(4):886-96. DOI: 10.1111/j.1471-4159.2004.02367.x. View

Cryan J, OLeary O, Jin S, Friedland J, Ouyang M, Hirsch B . Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors. Proc Natl Acad Sci U S A. 2004; 101(21):8186-91. PMC: 419578. DOI: 10.1073/pnas.0401080101. View

Lesch K . Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci. 2004; 29(3):174-84. PMC: 400687. View

Hindmarch I . Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur Psychiatry. 2004; 17 Suppl 3:294-9. DOI: 10.1016/s0924-9338(02)00653-3. View

Bhatnagar S, Sun L, Raber J, Maren S, Julius D, Dallman M . Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol Behav. 2004; 81(4):545-55. DOI: 10.1016/j.physbeh.2004.01.018. View

Duman R . Depression: a case of neuronal life and death?. Biol Psychiatry. 2004; 56(3):140-5. DOI: 10.1016/j.biopsych.2004.02.033. View

Mombereau C, Kaupmann K, van der Putten H, Cryan J . Altered response to benzodiazepine anxiolytics in mice lacking GABA B(1) receptors. Eur J Pharmacol. 2004; 497(1):119-20. DOI: 10.1016/j.ejphar.2004.06.036. View

Verkuyl J, Hemby S, Joels M . Chronic stress attenuates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur J Neurosci. 2004; 20(6):1665-73. DOI: 10.1111/j.1460-9568.2004.03568.x. View

Emrich H, von Zerssen D, Kissling W, Moller H, WINDORFER A . Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiatr Nervenkr (1970). 1980; 229(1):1-16. DOI: 10.1007/BF00343800. View

10.

Suzdak P, Gianutsos G . Parallel changes in the sensitivity of gamma-aminobutyric acid and noradrenergic receptors following chronic administration of antidepressant and GABAergic drugs. A possible role in affective disorders. Neuropharmacology. 1985; 24(3):217-22. DOI: 10.1016/0028-3908(85)90077-2. View

11.

Reul J, de Kloet E . Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 1985; 117(6):2505-11. DOI: 10.1210/endo-117-6-2505. View

12.

Yates M, Leake A, Candy J, Fairbairn A, McKeith I, Ferrier I . 5HT2 receptor changes in major depression. Biol Psychiatry. 1990; 27(5):489-96. DOI: 10.1016/0006-3223(90)90440-d. View

13.

Paul S, Purdy R . Neuroactive steroids. FASEB J. 1992; 6(6):2311-22. View

14.

Gould E, Cameron H, Daniels D, Woolley C, McEwen B . Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci. 1992; 12(9):3642-50. PMC: 6575731. View

15.

Pepin M, Pothier F, Barden N . Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol. 1992; 42(6):991-5. View

16.

Ferraro L, Tanganelli S, Calo G, Antonelli T, Fabrizi A, Acciarri N . Noradrenergic modulation of gamma-aminobutyric acid outflow from the human cerebral cortex. Brain Res. 1993; 629(1):103-8. DOI: 10.1016/0006-8993(93)90487-8. View

17.

Stec I, Barden N, Reul J, Holsboer F . Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res. 1994; 28(1):1-5. DOI: 10.1016/0022-3956(94)90031-0. View

18.

Rubin R, Phillips J, Sadow T, McCracken J . Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Arch Gen Psychiatry. 1995; 52(3):213-8. DOI: 10.1001/archpsyc.1995.03950150045009. View

19.

Maes M, Meltzer H, DHondt P, Cosyns P, Blockx P . Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoneuroendocrinology. 1995; 20(2):149-67. DOI: 10.1016/0306-4530(94)00049-g. View

20.

Young E, Akil H, Haskett R, Watson S . Evidence against changes in corticotroph CRF receptors in depressed patients. Biol Psychiatry. 1995; 37(6):355-63. DOI: 10.1016/0006-3223(94)00153-T. View